Search
for
Sort by
Research 30 of 1000+
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- <i>NUDT15</i>,<i>FTO</i>, and<i>RUNX1</i>genetic variants and thiopurine intolerance among Japanese patients with inflammatory bowel diseases
- Hair Loss in Patients with Inflammatory Bowel Disease
- Inflammatory bowel disease: pathogenesis, diagnosis and current therapeutic approach
- Frequency and associated factors of hair loss among patients with inflammatory bowel disease
- Gut instinct: Using tofacitinib to treat alopecia areata in the context of comorbid inflammatory bowel disease
- Alopecia Areata in an Adolescent With Inflammatory Bowel Disease
- Primary cicatricial alopecia and inflammatory bowel disease – is there a link?
- Scattered Skin Eruptions in a Patient With Inflammatory Bowel Disease
- P144 Vitamin C deficiency in inflammatory bowel disease: the forgotten micronutrient
- G42 Long term safety and efficacy of single dose parenteral iron in children with inflammatory bowel disease in a large tertiary centre
- Risk factors for the development of and outcomes after diagnosis of autoimmune alopecia areata in patients with inflammatory bowel diseases
- Nutritional aspect of pediatric inflammatory bowel disease: its clinical importance
- Symptom management in inflammatory bowel disease
- Cedrol ameliorates inflammatory bowel disease via mitochondrial biogenesis, gut microbiota restoration, and intestinal barrier repair
- Prevalence of skin lesions in a sample of Brazilian patients with inflammatory bowel disease
- Cutaneous side effects caused by treatment for inflammatory bowel disease
- Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease
- Cutaneous Manifestations in Biological-Treated Inflammatory Bowel Disease Patients: A Narrative Review
- Risk Factors for the Development of and Outcomes After Diagnosis of Autoimmune Alopecia Areata in Patients with Inflammatory Bowel Diseases
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases
- Adverse Events Associated with Azathioprine Treatment in Korean Pediatric Inflammatory Bowel Disease Patients
- Efficacy and safety of dual-targeted therapy for refractory inflammatory bowel disease: a retrospective case series from three tertiary general hospitals in China
- In-vitro and In-vivo Characterization of Gold Nanoparticles for the Treating of Inflammatory Bowel Disease
- NUDT15 R139C-related thiopurine leukocytopenia is mediated by 6-thioguanine nucleotide-independent mechanism in Japanese patients with inflammatory bowel disease
- Alopecia Areata: A possible extraintestinal manifestation of Crohn's disease
- Skin Manifestations Associated with Autoimmune Liver Diseases: a Systematic Review
- Pyoderma gangrenosum presented as generalized pustules in a patient with Crohn’s disease
- Skin Manifestations of Rheumatological Diseases